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EditorialCell Metabolism: Why, and why now?In a time when scientific journals have proliferated in number,
researchers studying metabolism and its disorders have faced
an unusual problem. Despite the fact that metabolic diseases
including obesity, diabetes, hypertension, and atherosclerotic
heart diseases are among the most common, costly, and diffi-
cult to manage chronic conditions affecting mankind, there has
not been a single forum for high-quality research in this broad,
dynamic, and expanding area of research, until now.
Basic metabolism, which following the birth of molecular bi-
ology appeared passé to many, is in the midst of a renaissance
with the realization that many diseases, including those listed
above, result from alterations in either newly defined or clas-
sic metabolic pathways. In aggregate, these diseases have
emerged as the major sources of morbidity and mortality in the
developed world and an increasing problem in the developing
world. Patient studies over recent years have also shown that
individuals who are clinically normal but have insulin resis-
tance, increased central fat distribution, low plasma HDL, and
high plasma triglycerides are at an especially increased vascu-
lar risk. This so-called “metabolic syndrome” has rightly be-
come the focus of intense attention from the general public,
health care providers, public health officials, and the pharma-
ceutical industry.
These diseases have also attracted increasing attention from
the scientific community, with transforming progress in our un-
derstanding of the molecular basis of metabolic disease and
an explosion in the number of high-quality research reports.
Despite this, no single journal has provided an adequate and
focused forum for basic and clinical research on metabolism,
the metabolic syndrome, and related areas. That is, scientists
studying these problems have not had a journal whose table
of contents is a “must read” each month. In Cell Metabolism,
these scientists can give voice to their efforts to understand
the molecular basis of metabolic disease, integrate metabolism
and modern molecular science, and have a single place where
they and the broader scientific community can track the stun-
ning progress in these fields.
Cell Metabolism will provide a forum for the publication of
scientific articles of the highest quality and impact with rele-
vance to research in the areas of obesity, diabetes, and related
metabolic and cardiovascular disorders. This journal will also
provide a forum for articles in the field of metabolism, broadly
construed, including nutrition, aspects of genetics and gene-
environment interactions, mitochondrial biology and energy ex-
penditure, hormone action and signal transduction, epidemiol-CELL METABOLISM : JANUARY 2005 · VOL. 1 · COPYRIGHT © 2005 ELogy, bone physiology, and others. Cell Metabolism will capture
the excitement that has accompanied recent advances includ-
ing the identification of the signal transduction pathways by
which cholesterol, glucose, and lipid are sensed, nutrient sens-
ing by the TOR and AMPK pathways in vertebrates and inver-
tebrates, studies of the effects of specific nutrients on gene
expression and metabolism, sensing of Redox state by the
transcriptional and cellular machinery, the role of the CNS in
controlling behavior and metabolism, studies of energy metab-
olism in mitochondria, understanding peptide and nuclear hor-
mone action, advances in our understanding of bone homeo-
stasis, and others too numerous to list.
Overlying this basic science are studies of the all too com-
mon diseases of obesity, diabetes, hyperlipidemia, hyperten-
sion, and the “metabolic syndrome.” A fuller understanding of
the basis for the frequent association of the diseases that con-
stitute “metabolic syndrome” is likely to fuel significant medical
progress in their diagnosis and treatment. The fields of me-
tabolism and metabolic disease are thus interdisciplinary, and
Cell Metabolism will provide a monthly forum for basic and
clinical researchers to follow each others’ progress.
Metabolic disease is the subject of frequent and increasing
attention from the general public. Despite this, basic scientists
in this broad and expanding area have not had a “home” from
which to express their views about the causes of metabolic
disease and what to do about it. The lack of a forum to address
policy issues and societal views has perhaps contributed to
the simplistic view, held by much of the public, that metabolic
disease is primarily a consequence of poor lifestyle choices
and that a deeper understanding of the molecular basis of
these conditions is not essential. This journal will thus also pro-
vide scientists with an opportunity to express their views, ulti-
mately helping frame public discussion on what are the most
prevalent disorders afflicting our population.
This new journal will address a spectrum of unmet needs in
the areas of metabolism and metabolic disease. Please wel-
come Cell Metabolism to your bookshelves.
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